← Home
🚀 Sign up Free for Company Insights & Valuation!
Sign up for free to get access to the best public company valuation and insights. Get started today and unlock the potential of your investments!
Sign up free
Lonza Group
Pharma / Pharmaceutical and Biotechnology Manufacturing
At a Glance | Core Facts | Company Due Diligence | Industry Due Diligence | Competitors | Stock Swings | News | Income | Balance | Cash Flow | Growth | Enterprise | Ratios | Metrics | Dividends | Risks | SWOT | Porter's Five Forces | PEST | Score Positive | Clusters | Reports | WebCore Facts
CEO | Dr. Wolfgang Wienand Ph.D. |
Employees | 18686 |
Phone | 41 61 316 81 11 |
Address | Muenchensteinerstrasse 38 Basel 04002 CH |
IPO Date | 2009-02-13 |
Average Volumes | 124 |
Market Cap | 39.629 bil USD |
Div >7% since | N/A |
Web | https://www.lonza.com |
ISIN | CH0013841017 |
NASDAQ ticker | LZAGF |
News on YouTube | YouTube |
SEC | 'Lonza Group' on SEC |
Reports | 'Lonza Group' Reports |
CUSIP | N/A |
Wait! There's more — sign up for free or log in